IHS Chemical Week

People & Business :: Emerging Companies

Enzon Pharmaceuticals to Spin Off Unit

May 19, 2008 | Deepti Ramesh

Enzon Pharmaceuticals (Bridgewater, NJ) says it plans to spin off its novel biotechnology business to create separate biotechnology and speciality pharmaceutical public companies. The transaction is expected to be completed in the fourth quarter. “The opportunities for both the specialty pharmaceutical business and the biotechnology business could be substantially enhanced, and greater value could be created than under the current structure,” says Jeffrey Buchalter, chairman, president, and CEO of Enzon. “Operating separately will allow each...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa